Globus Medical, Inc.
GMED
$71.04
$1.361.95%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -48.87% | 63.21% | 546.26% | -147.34% | 1,406.41% |
| Total Depreciation and Amortization | 1.91% | 5.28% | 15.07% | -22.34% | 90.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.63% | -34.08% | 61.55% | -26.48% | 366.57% |
| Change in Net Operating Assets | -21.78% | 129.80% | -173.79% | 5.91% | -2,749.97% |
| Cash from Operations | 3.28% | 275.34% | 3.57% | -49.95% | 107.34% |
| Capital Expenditure | 59.21% | -50.92% | 2.70% | -24.85% | -6.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 97.95% | 61.37% | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -421.25% | 21.42% | 515.61% | -101.56% | 46.77% |
| Cash from Investing | -595.68% | -44.22% | 77.72% | -114.53% | 496.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 194.76% | 65.09% | 317.17% | 228.17% | -68.48% |
| Repurchase of Common Stock | -11.19% | 59.67% | 97.65% | 62.46% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -179.56% | 10.56% | 88.69% | -1,330.08% | -13.71% |
| Cash from Financing | 205.02% | 124.86% | 107.53% | 51.23% | -16,750.53% |
| Foreign Exchange rate Adjustments | -205.06% | 7.92% | 213.92% | -854.47% | -116.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.86% | 276.75% | 149.78% | -160.33% | 799.43% |
